Clinical trial
Non-Myeloablative Allogeneic Transplant for Myelodysplastic Syndromes and…
NCT00186576 · Stanford University, Other · Completed
Key facts
| NCT number | NCT00186576 |
|---|---|
| Title | Non-Myeloablative Allogeneic Transplant for Myelodysplastic Syndromes and Myeloproliferative Disorders |
| Official title | Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation for Treatment of Myelodysplastic Syndromes and Myeloproliferative Disorders (Except CML) |
| Lead sponsor | Stanford University, Other |
| Collaborators | National Institutes of Health (NIH) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Myelodysplastic Syndromes, Myeloproliferative Disorders, Blood and Marrow Transplant (BMT), Myelodysplastic Syndromes (MDS), Myeloproliferative Disorders (MPD) |
| Intervention type | Procedure |
| Interventions | nonmyeloablative allogeneic hematopoietic cell transplant |
| Enrollment | 40 |
| Start date | Dec 1, 2001 |
| Primary completion | Mar 1, 2004 |
| Completion | Jul 1, 2010 |
| First posted | Sep 16, 2005 |
| Last update posted | Oct 14, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: